Skip to content
Search

Latest Stories

UK to speed up Covid-19 testing as criticism grows

Britain's government said on Wednesday (1) it would ramp up the number of coronavirus tests amid widespread criticism that it was doing far too few, as ministers suggested that shortages of chemicals were partly to blame.

Officials say testing for Covid-19 is key to fighting it, not least to check if medics on the frontline of the epidemic could return to work.


But while Germany has been testing about 500,000 people a week, Britain's current capacity is just 12,750 a day, a figure the government said it was aiming to double by mid-April.

"I hope on testing ... you will see significant increases this week. We expect to be at 15,000 tests over the course of this week and then moving further forward in the future," housing minister Robert Jenrick told broadcaster ITV.

"We do need to go further and we need to do that faster."

The number of coronavirus deaths in Britain rose to 1,789 people, figures on Tuesday (31) showed, a 27 per cent  increase in a day with one of the victims a 13-year-old boy with no apparent underlying health conditions.

So far, tests have been focused on those suspected to have the virus who have been admitted to hospital but the government says it is trying to extend this to key staff in the National Health Service (NHS).

Jenrick said more than 900 health workers were tested over the weekend and a further 8,240 individuals on Monday, as he faced a barrage of questions in media interviews about the low number of tests.

"Fix Testing Fiasco Now," the Daily Mail newspaper said on its front page.

At a news conference on Tuesday, Cabinet Office minister Michael Gove said shortages of necessary chemicals had been a factor.

"A critical constraint on the ability to rapidly increase testing capacity is the availability of the chemical reagents which are necessary in the testing," he said, saying the government was working with companies worldwide to obtain what was required.

The Chemical Industries Association said that, while there was escalating demand, "there are reagents being manufactured and delivered to the NHS".

"Every business here in the UK and globally is looking at what they can do to help meet the demand as a matter of urgency," it said in a statement.

An opposition Labour lawmaker said the problem was that ministers appeared not to have ordered enough of the chemicals from companies that had offered to make what the government needed.

"These are often the same chemical companies which are producing chemicals for the tests in Germany," Bill Esterson said.

"Companies in the UK can make them. They haven't been asked. The shortage is because they haven't been ordered."

Asked about the apparent discrepancy between the government and industry over the shortages, Jenrick said several chemicals were required, "and not all of them, as I understand it, have always been available in the UK in the quantities that we need."

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less